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Abstract
Adult human heart mitochondrial DNA (mtDNA) has recently been shown to have a complex organization with abundant
dimeric molecules, branched structures and four-way junctions. In order to understand the physiological significance of the
heart-specific mtDNA maintenance mode and to find conditions that modify human heart mtDNA structure and replication,
we analyzed healthy human heart of various ages as well as several different heart diseases, including ischemic heart
disease, dilated as well as hypertrophic cardiomyopathies, and several mitochondrial disorders. By using one- and two-
dimensional agarose gel electrophoresis, various enzymatic treatments and quantitative PCR we found that in human
newborns heart mtDNA has a simple organization, lacking junctional forms and dimers. The adult-type branched forms are
acquired in the early childhood, correlating with an increase in mtDNA copy number. Mitochondrial disorders involving
either mutations in the mtDNA polymerase c (PolGa) or mtDNA helicase Twinkle, while having no obvious cardiac
manifestation, show distinct mtDNA maintenance phenotypes, which are not seen in various types of diseased heart or in
mitochondrial disorders caused by point mutations or large-scale deletions of mtDNA. The findings suggest a link between
cardiac muscle development, mtDNA copy number, replication mode and topological organization. Additionally, we show
that Twinkle might have a direct role in the maintenance of four-way junctions in human heart mtDNA.
Citation: Pohjoisma¨ki JLO, Goffart S, Taylor RW, Turnbull DM, Suomalainen A, et al. (2010) Developmental and Pathological Changes in the Human Cardiac
Muscle Mitochondrial DNA Organization, Replication and Copy Number. PLoS ONE 5(5): e10426. doi:10.1371/journal.pone.0010426
Editor: Antoni L. Andreu, Hospital Vall d’Hebron, Spain
Received February 4, 2010; Accepted April 8, 2010; Published May 3, 2010
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: JLP was funded by the EU’s 7th Framework Program Collaborative Project, AtheroRemo. RWT and DMT acknowledge the continuing financial support
of a Wellcome Trust Programme Grant and the Newcastle upon Tyne Hospitals NHS Trust. Mitochondrial diagnostic testing in Newcastle is funded by the UK
National Comissioning Group to provide the ‘‘Rare Mitochondrial Disorders of Adults and Children’’ Diagnostics Service. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Jaakko.Pohjoismaki@uta.fi
Introduction
The heart is the most energy demanding tissue in the human
body consuming 0.1 ml O2/g per minute – an amount that is only
surpassed by insect flight muscles [1]. Heart has also an impressive
reserve capacity; human cardiac muscle oxygen consumption can
rise four-fold without any effect on the steady-state ATP levels.
There is also no accumulation of oxygen debt, as seen in skeletal
muscles under prolonged exercise. The continuous circulatory
pumping of blood by the heart as well as the maintenance of ion
homeostasis in cardiomyocytes is dependent on healthy mitochon-
drial function [2]. The importance of oxidative metabolism is
highlighted by the high mitochondrial content of heart muscle cells,
where up to 40% of the cellular volume can consist of mitochondria.
The high energy requirements of heart manifest also in a high
mtDNA content. The few studies including adult human cardiac
muscle propose a mean copy number of 69706920 to 923565457
mtDNA per cell, with individual numbers ranging from 4 000 to
up to 34 000 [3,4]. For comparison, skeletal muscle cells,
depending on the muscle, have copy numbers ranging from
1000 to 4000 mtDNA molecules per cell.
The human 16,569 bp mitochondrial genome is typically seen
in cells as monomeric, double-stranded, covalently closed circles.
However, according to our recent findings, a major fraction of
human heart mtDNA exist as dimers and is organized in highly
complex, branched molecules, containing sometimes dozens of
genome equivalents [5]. These structures contain three- and four-
way DNA junctions, indicating active replication and recombina-
tion, somewhat resembling DNA replication in T-even phages [6],
malarial mtDNA [7] as well as some plant and yeast mitochondria
[8,9]. Also the human brain has a subpopulation of molecules
having similar features, while other tissues and cultured cells
replicate their mtDNA using a standard theta-mechanism but
incorporating extensive stretches of ribonucleotides on the lagging-
strand [10,11].
For unknown reasons, the recombining-replicating forms of
mtDNA seem at present to be a feature specific to human heart
and they have not been found in mice, rats, rabbits or pigs [5].
Despite the fact that neither the mitochondrial DNA binding
protein TFAM nor Twinkle can promote recombination in
cultured mammalian cells [12,13], the overexpression of either
TFAM or the mtDNA helicase Twinkle in transgenic mouse
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hearts induces an increase in complex DNA forms and
recombination junctions, indicating that recombination
mediating mechanisms occur also in other mammals under
specific conditions [5]. Interestingly, the TFAM overexpressing
mice are protected against the adverse effects of ischemia
suggesting that mtDNA could play a role in cardiac remodeling
[14].
To further characterize conditions that modify of the complex
human heart mtDNA organization, we have analyzed the effect of
age and the consequences of different cardiac diseases on heart
mtDNA maintenance in human heart. While we did not observe
any qualitative changes in the organization or replication of
mtDNA in classified heart diseases, we discovered that cardiomy-
ocytes of human newborns have a simple mtDNA organization,
with relatively little recombination intermediates and dimeric
molecules. The adult-type maintenance mode is acquired in the
first years of life, correlating with a drastic increase in mtDNA
copy number.
A dominant negative Twinkle mutation (aa 352–364 duplica-
tion), associated with a late-onset myopathy, completely abolished
the adult-type mtDNA recombination phenotype and organiza-
tion, including dimeric molecules without any effect on mtDNA
copy number. In contrast, a mutation in the catalytic subumit of
DNA polymerase c (PolGa;p.-G848S/p-S1104C) mutation influ-
enced only the maintenance of dimeric mitochondrial genomes in
adult human heart. These results suggest that Twinkle is directly
involved in the maintenance of mtDNA recombination in adult
human heart.
Results
In order to detect aging related changes in mtDNA replication
intermediates (mtRIs) we analyzed 24 healthy left ventricular heart
samples from individuals aged 0–83 years by using the two-
dimensional agarose gel electrophoresis (2D-AGE) methodology
(Table 1). We also compared the heart mtRI patterns from
individuals with a fatal heart disease or with various mitochondrial
disorders, to the mtRI patterns of age-matched healthy hearts
(Table 2). We screened only for clear-cut effects, such changes in
the replication mode or drastic reduction in the relative quantities
of molecules with four-way junctions.
Lack of junctional mtDNA forms in newborn human
heart
When analyzing the age dependency of junctional mtDNA
forms in healthy humans, we noticed that notably less mtRIs
existed in newborns and that four-way junctional mtDNA
molecules – a feature typical to adult heart – were undetectable
(Figure 1). Instead, some high-molecular weight forms, resembling
a modified slow-moving Y-arc, could be seen (Figure 1B: m).
These arcs were similar to the ones seen in tissues having
ribonucleotide-incorporating replication intermediates [5]. The
mtDNA replication pattern of a case with a fatal, neonatal
mitochondrial disease with biventricular hypertrophic cardiomy-
opathy due to a pathogenic homoplasmic m.1624C.T MT-TV
(see [15] for detailed description), was comparable with the age-
matched controls (Figure 1B). Further analysis of mtRIs from
young children of various ages showed a gradual shift to the adult-
type mtDNA pattern (Figure 2). The four-way junctional forms
seemed to increase already in the first years of life, being
comparable with those of adults before the age of ten. Notably,
unlike in adult human hearts, in 2D-AGE of PvuII digested heart
mtDNA of newborns, a faint bubble arc can be seen (Figure 2B:
bu) indicating that at least some molecules are replicating via the
theta-replication mode typical for cultured cells and most
mammalian tissues [5]. It should be noted that also in normal
mouse heart mtRIs patterns are weak and theta type replication
bubbles can be best detected using single-cut 2D-AGE conditions
[5].
Twinkle mutation modifies the mtDNA replication mode
in adult human heart
In contrast to the clear-cut differences observed in young
children compared to the adult mtDNA, we were unable to detect
any changes in the mtDNA replication or organization in diseased
hearts, including cases with acute ischemic myocardial infarction
without previous heart disease manifestation, old myocardial
infarction with a long history of ischemic heart disease, as well as
with cases with dilating and hypertrophic cardiomyopathy,
ischemic cardiomyopathy and various mitochondrial disorders
(Figure 3). Besides investigating patients with cardiac manifesta-
tions due to specific mtDNA point mutations, our series of
mitochondrial disorders also included three patients with Twinkle
dup352–364 mutation resulting in autosomal dominant progres-
sive external ophtalmoplegia (adPEO) [16,17], a patient with an
Table 1. Details of the left ventricular heart muscle samples
from healthy controls used in this study.
Age Sex Cause of death
Additional
disease Notes
Controls 1 day M Transposition of the
great arteries (TGA)
No
1 day F Intrauterine hypoxia No
1 day M Primary pulmonary
hypertension
No
5 mo M Meningitis No
2 M Accidental poisoning No
3 M Gastroenteritis No
8 F Gastroenteritis No
9 F Grand mal status
epilepticus
Congenital
brain trauma
12 M Traffic accident No
12 F Pneumonia No
16 M Opportunistic mycosis
caused by medication
No
17 F Traffic accident No
18 M Traffic accident No
19 M Suicidal poisoning No
22 M Suicide by rifle No
23 M Suicide by shotgun No
31 F Suicide by motor vehicle No
40 M Suicidal poisoning No
52 M Traffic accident No
53 M Suicide by handgun No
55 M Accidental suffocation No
71 M Drowning No
78 F Suicide by strangulation No
83 F Suicide by strangulation No
Age, sex, cause of death and disease status specified. M=Male, F = Female.
doi:10.1371/journal.pone.0010426.t001
Human Heart mtDNA Maintenance
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extrapyramidal syndrome resulting from a compound heterozy-
gous mutations affecting the a-subunit of the mtDNA polymerase,
PolG (p.-G848S/p-S1104C, see [18]) and a patient carrying a
3978 bp single, large-scale mtDNA deletion (11657:15636),
flanked by a 12 bp direct repeat, who presented with Kearns-
Sayre syndrome (KSS). Of these patients, only the Twinkle
dup352–364 cases showed a phenotype on 2D-AGE (Figure 4). In
these samples almost complete abolishment of the recombination
intermediates was seen (Figure 4B:ii), while the replication bubbles
typical for theta-replication were retained (Figure 4B:iv). As
mentioned earlier, unlike humans, mouse heart mtDNA does not
have abundant recombination intermediates and mtRIs are
seemingly similar as in other tissues [5] (Figure 4D). Whereas
overexpression of wild-type Twinkle promote recombination of
mouse heart mtDNA, mice carrying the Twinkle dup352–364
mutation show a strong mtDNA replication stalling phenotype,
similar to the one observed in cultured cells expressing the same
mutation [19]. The expression level of the transgene in these mice
is comparable to – or even lower than would be expected in
human heterozygous condition [20].
Changes in heart mtDNA replication and organization
correlate with copy number and with mutations affecting
Twinkle or PolGa
When analyzing the topological organization of mtDNA, we
noticed that the high molecular weight (HMW) forms and dimeric
mtDNA molecules seen in adult human heart were undetectable in
infants, but gradually increase together with the appearance of the
recombination junctions (Figure 5A). In the adPEO patients with
Twinkle mutation, almost all complex mtDNA forms were
missing, including dimeric molecules (Figure 5B). The patient
with PolG mutations seem to retain most junctional forms but has
a drastic reduction in all dimeric mtDNA forms.
Overall, in the analyzed adult heart muscle samples there is
some individual variation in the quantities of the different mtDNA
Table 2. Details of the left ventricular heart muscle samples of individuals with a fatal diagnosed heart disease or a mitochondrial
disorder.
Age Sex Cause of death Additional disease Notes
Myocardial infarction 46 M Acute infarct Ischemic cardiomyopathy
50 F Acute infarct Ischemic cardiomyopathy
58 M Old infarct Coronary heart disease
64 M Old infarct Coronary heart disease
65 M Old infarct Coronary heart disease
73 F Acute infarct Ischemic cardiomyopathy
83 F By-pass surgery complication Coronary heart disease
84 M Acute infarct Coronary heart disease
Cardiomyopathies 24 F DCM No
35 F HCM No Ealier cardiac arrest, successful resuscitation
44 M HCM Coronary heart disease
48 M HCM No
55 M Unspecified cardiomyopathy No
59 M Unspecified cardiomyopathy No
76 M DCM No
81 M Ischemic cardiomyopathy Coronary heart disease
84 M DCM, Mitral stenosis No
Mitochondrial 1 day F Lactic acidosis, cardiac failure Fatal neonatal
mitochondrial disease
homoplasmic m.1624C.T MT-TV mutation, [15]
34 F Cardiac arrest following seizure MELAS m.3243A.G MT-TL1 mutation, unpublished
41 F Pneumonia KSS 4.0 kb single, large-scale mtDNA deletion,
unpublished
50 M Cardiomyopathy Hearing loss, myopathy,
heart failure
m.7472Cins + m.7472A.C MT-TS1 mutation, [35]
52 F Pneumonia MELAS m.3243A.G MT-TL1 mutation, unpublished
55 M myocardial infarction Myopathy/ataxia m.14709T.C MT-TE mutation, [36]
59 F Pneumonia MELAS m.3243A.G MT-TL1 mutation, unpublished
59 M Aspiration pneumonia Parkinsonism,
extrapyramidal syndrome
multiple mtDNA deletions - compound POLG
mutations, [18]
60 M Respiratory insufficiency adPEO Twinkle dup352–364 [16]
60 F Respiratory insufficiency adPEO Twinkle dup352–364 [16]
73 F Suicide adPEO Twinkle dup352–364 [16]
DCM= Dilating cardiomyopathy, HCM= Hypertrophic cardiomyopathy.
doi:10.1371/journal.pone.0010426.t002
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Figure 1. Specific change in human heart mtDNA replication and recombination in early childhood. (A) A diagram of human mtDNA
showing the analyzed DraI ND5 probed fragment (nt 12,271-16,010, probe location denoted with *) and resulting molecular forms of the fragment
after digest. Simple, dsDNA replication fork migrate on the Y-arc (y), four-way junctional molecules on the X-arc (X). (B) 2D-AGE of the DraI ND5
fragment from a one-day old newborn, five-month old, three-years old, eight-years old human heart mtDNA and a one-day old neonate with
mitochondrial disease due to a homoplasmic m.1624C.T mutation. Notice the accumulation of X-arc signal and an overall increase in replication
intermediates with aging. Degraded slow-moving Y-arc structures (m), indicators of ribonucleotide-incorporating replication, can be seen on some of
the samples (see also [5].).
doi:10.1371/journal.pone.0010426.g001
Figure 2. Theta-type mtRIs in infant heart. (A) A diagram of human mtDNA showing the probe location (*), the PvuII cut site (nt 2565) and the
resulting molecular forms after digest. In the case of unidirectional theta-replication originating from the OH, the molecules containing replication
bubbles form almost complete bubble-arc (bu) on the 2D-AGE. Y- or Y-like arc likely results from initiation outside OH but can in the case of human
heart mtDNA also contain more diverse forms of mtRIs (see [5] for further explanation). (B) Single-cut PvuII 2D-AGE analysis of the samples in Figure 1.
Faint bubble-arcs seen at younger age are gradually replaced by X- and Y-forms of much stronger intensity. Heart mtRIs from children aged 8–10
years show no difference to the adult mtRI forms.
doi:10.1371/journal.pone.0010426.g002
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forms, but this does not seem to be connected to the pathology or
age. Curiously, in the case of the KSS patient with the ,4.0 kb
common deletion, deleted molecules cannot be detected without
digesting the mtDNA with a restriction enzyme (Figure S1),
indicating that the majority of the deletions in heart is probably
associated with larger molecules.
To see whether the increase in the complexity of mtDNA
organization from newborns to adults also manifests as an increase
in mtDNA copy number, a Real-Time quantitative PCR (qPCR)
assay was performed (Figure 6). As expected, newborn babies seem
to have almost five-fold lower heart mtDNA copy numbers than
adults and the copy number steadily increased concomitantly with
the changes in mtDNA organization and replication. Interestingly
neither Twinkle nor the compound PolG mutations seemed to
deplete mtDNA in heart. As Miller et al. [3], we did not observe
any age dependency in human heart mtDNA copy number in
adults.
Discussion
Relationship of heart mtDNA replication, organization
and copy number
We report here that newborn human heart mtDNA has a
relatively simple organization, lacking dimeric molecules and
abundant recombination intermediates and bearing resemblance
to the mtDNA of mouse heart or human skeletal muscle [5]. The
adult type organization develops gradually in infancy with a
concomitant rise in the mtDNA copy number. It is reasonable that
these changes are related to the switching from fetal heart program
to meet the metabolic requirements of adult heart.
As the highly complex branched forms of adult heart mtDNA
harbor multiple copies of the genome it is likely that they also
represent the nucleoid organization inside the mitochondria,
where several copies may provide more chances for molecules to
recombine. The idea of mtDNA density-induced recombination is
further supported by the appearance of high molecular weight
mtDNA forms and recombination intermediates in tissues with
increased copy number in mice overexpressing Twinkle or TFAM.
[5]. A similar phenomenon is seen in phage T4, where complex
molecular networks are formed only when there are many
genomes present in the same cell [6].
The role of Twinkle and PolGa in heart mtDNA
maintenance
We have earlier shown that the overexpression of wild-type
Twinkle in mouse heart promotes recombination junction
formation together with an increase in mtDNA copy number [5]
(Figure 4D), whereas the Twinkle dup352–364 mutation has been
shown to impair helicase activity, resulting in a strong replication
stalling phenotype in cultured cells as well as in mice [19]. In
cultured cells overexpression of the mutated helicase leads to rapid
mtDNA copy number depletion, however in the heterozygous
stage mice and humans typically do not show any mtDNA
depletion, but accumulation of deleted mtDNA molecules in
various tissues [16,20]. The data presented here further suggests
that the mutation does not have as severe deleterious effects on
mtDNA replication as it has on recombination - resulting in almost
complete abolishment of the otherwise abundant heart mtDNA
recombination intermediates.
Mice carrying the Twinkle dup352–364 mutation did not show
any cardiac phenotype [20]. However in some, but not all the
Twinkle dup352–364 patients of the same family, asymptomatic,
left cardioventricular hypertrophy, sinus bradycardia and ischemic
changes were detected [16]. It is unclear if the heart phenotype of
Figure 3. No qualitative change mtDNA replication and recombination intermediates in diseased human hearts. All analyzed samples
retained the typical strong X-arc (X) and showed no evidence of ribonucleotide-incorporating replication intermediates. (A) A diagram of human
mtDNA showing the analyzed DraI ND5 probed fragment as earlier, followed by 2D-AGE panels of this representing (B) a male 46 years, acute
ischemia, (C) male 84 years, chronic ischemia, (D) male 46, hypertrophic cardiomyopathy, (E) female 24, dilating cardiomyopathy, (F) mitochondrial
cardiomyopathy, m.14709 T.C mutation, (G) mitochondrial cardiomyopathy (m.7472Cins + m.7472A.C), (H) m.3243A.G MELAS, (I) PolG (p.G848S/
p. S1104C) mutation, (J) KSS (,4.0 kb single mtDNA deletion, see also Figure S1), (K) a healthy control male, 19 years and (L) a healthy control female,
83 years.
doi:10.1371/journal.pone.0010426.g003
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the patients is related to the Twinkle mutation. Obviously also the
wild-type mice and adolescent humans can thrive without adult
human-type mtDNA maintenance mode, meaning that the
benefits of such a mode must be restricted to only very special
physiological context.
Based on the data from various other genetic systems, one
would expect replication stalling to result in an increase in double-
strand breaks, which in turn are mostly repaired by recombination
[21,22]. If Twinkle’s effect on recombination junction formation is
as direct as the data suggest, the observed deleted mtDNA
molecules in adPEO patients could equally be an end result of
compromised recombination machinery instead of abortive
replication [23]. A strong indication for such a repair system
comes from the fact that the saturation of mitochondrial DSB
repair machinery by a mitochondrially targeted endonuclease
results in deleted mtDNA molecules that – unlike mtDNA
deletions in healthy heart – do not have homology in the break-
points, indicating that they are generated by non-homologous end
joining [24].
In the adPEO patients the relationship between mtDNA copy
number and structural maintenance is not as straight-forward as
could be inferred from the data from the developmental changes
in childhood. Twinkle seems to be required for the maintenance of
the four-way junctions and complex mtDNA forms in adult heart,
but it seems that this function is separate from the copy number
control in this tissue. However, as we are only observing an end
result in the adult patient hearts it is difficult to address whether
some adaptive mechanisms have been involved.
Otherwise, the importance of Twinkle in mtDNA recombina-
tion is not surprising, as the maintenance of recombination
intermediates requires a helicase [25], albeit generally different
from replicative helicases. However, as many mitochondrial
proteins have functional redundancy and no mammalian mito-
chondrial recombinases are known to-date it might well be that in
certain cellular conditions Twinkle could carry out more functions
than expected. It should be noted that via homology to T7 DNA-
helicase Twinkle is included in the family of DnaB-helicase family
and thus in turn related to the RecA family of recombinases
[17,26].
In the PolG (p. G848S/p.S1104C) mutant patient heart the
mtDNA copy number is not dramatically affected in the heart of
the patient and X-forms are present on the 2D-AGE panel
(Figure 3I), however the dimeric linear 33 kb molecules as well as
HMW mtDNA forms are almost completely absent (Figure 5).
Most of the HMWs that can be resolved in regular agarose gel
electrophoresis consist of dimeric circles [5] and the reduction in
the HMW signal is mostly due to the absence of most dimeric
forms. The p.G848S mutation is located in the catalytic domain of
Figure 4. Theta-type mtDNA replication in heart muscle of adult adPEO patients with Twinkle dup352–364 mutation. (A) Human
mtDNA showing the DraI and PvuII cut sites and probe locations. (B) Comparable exposures of 2D-AGE analysis of DraI ND5 fragment (i–ii) and PvuII
(iii–iv) cut heart mtDNA from an age matched healthy control (i, iii) and adPEO patient (ii, iv). As a striking difference to the control samples, an almost
complete absence of recombination intermediates (X) and a strong bubble arc (bu) in the adPEO heart muscle can be seen. (C) Mouse mtDNA
showing MluI cut site (nt 1771) that is comparable to the human mtDNA PvuII cut site location. (D) 2D-AGE of a MluI cut heart mtDNA from a control
mouse, Twinkle overexpressor (oe) mouse and a mouse expressing the human Twinkle dup342-364 mutation. Whereas wild-type Twinkle enhances
recombination junction formation, dup342-364 results in strong replication stalling phenotype in mouse heart. Unlike in mice, the overall intensity in
the mtRIs of human adPEO patient heart is rather lower when compared to the age matched control hearts.
doi:10.1371/journal.pone.0010426.g004
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the protein and severely impairs the enzyme’s polymerase activity
in vitro [27]. As the Twinkle patients also showed complete absence
of dimeric mtDNA molecules, this could indicate that they are
primarily generated via recombination but later maintained by
replication. As in mouse mitochondria the dimeric circular
molecules take up to three times longer to replicate than
monomers [28], the dimeric and larger genomes might simply
be selected out when the mtDNA synthesis rate is reduced.
The p.G848S mutation in compound heterozygosity has been
reported in patients with Progressive External Ophtalmoplegia
(PEO) and Alpers-Huttenlocher syndrome with mtDNA depletion
[29–31]. Similar to our case, the p.G848S mutation in compound
with a heterozygous p.T251I mutation has been found in a family
with autosomal recessive PEO and multiple mtDNA deletions in
muscle [29]. It is not clear how the same mutation can be
associated with either multiple deletions or depletion of mtDNA,
but variability of clinical and molecular phenotypes seem to be
common in PolG disease mutations [32].
The results from both the Twinkle and PolG patients provide
some insight into the tissue specific features of many mitochondrial
disorders. Overall speed of mtDNA replication synthesis, turnover,
mtDNA organization and the existence of backup mechanisms,
such as active recombination, could be limiting for many disease
mutations of mtDNA maintenance proteins that do not show any
phenotype in cultured cells or in vitro [19,33]. These variables have
been largely neglected when mitochondrial diseases have been
studied. Simple Southern analysis of different topological forms of
mtDNA could prove to be highly informative when characterizing
Figure 5. Human heart mtDNA topology changes in early childhood and in mitochondrial disorders involving mutations in Twinkle
and PolG. The basis of the assignment of the different molecular forms is presented in [5]. (A) Newborns and young children have mainly
monomeric open circular (1n oc), monomeric linear (16.6 kb) and monomeric supercoiled (1n sc) mtDNA molecules. Dimeric molecules, such as
dimeric linears (33 kb) and complex mtDNA forms increase in early childhood. The quantities of different forms vary in adults and do not seem to
depend on age or pathological status (data not shown). However, in an adult adPEO cases having Twinkle dup342-354 or with PolG (p.G848S/p.
S1104C) compound mutation (PolG) the newborn-type mtDNA organization, including the monomeric supercoils are retained (B). T7 endonuclease I
(T7 endoI) cleaves specifically branched DNA structures. Digestion of the heart DNA from the PolG patient shows that majority of the mtDNA
molecules also in the branched structures are monomeric and there are around 14-fold less dimeric molecules than in the age matched control heart
(male 44 years). In control heart, dimeric circular (2n oc) mtDNA molecules among the high molecular weight forms persist after T7 endoI, wheras
they are not present in Twinkle adPEO patients and greatly decreased in the patient with mutant PolG. The other HMW forms being resistant to T7
endoI are catenanes (cat). As a comparison, in human skeletal muscle (ilio-psoas) there are very few T7 endo I sensitive molecules, showing that
complex branched mtDNA forms are still present in the PolG mutant patient heart (See also Ref #5 for the assignment of the different molecular
forms of human heart mtDNA). (C) Phosphoimager quantification of different mtDNA forms in cardiac muscle from one-day old newborns, young
children (2–8 years) and adults. Statistically significant differences in high molecular weight (MW) forms, dimeric and monomeric molecules were
detected (p-values; Students t-test). It should be noted that linear molecules are likely to arise due to artefactual breakage of mtDNA and can vary in
post mortem samples depending on sample preservation.
doi:10.1371/journal.pone.0010426.g005
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the phenotype of mitochondrial disorders. More studies on the
intrinsic and extrinsic factors affecting mtDNA replication and
topology, especially in mouse models, will contribute to the
understanding of the disease mechanisms and the healthy
maintenance of mtDNA organization.
Materials and Methods
Autopsy series
The series comprises of left ventricular cardiac muscle samples
from 24 autopsy cases (ages 0–83 years, Table 1) without any
diagnosed heart disease, 17 cases with various heart diseases
diagnosed at autopsy and 14 cases with a mitochondrial disease
(Table 2). The samples originating from the Newcastle University
were obtained with Institutional Ethical Approval and with a
written consent of the family. The consent was given after the
death and prior to the autopsy of the patient (within 4 hours of
death). The samples from the University of Helsinki were collected
with Institutional Ethical Approval and with verbal consent of
next-to-kin. The consent was given after the death and prior to the
autopsy of the patient (within 2–48 hours of death). The consent is
documented in the medical records of the deceased. Verbal
consent was the standard procedure at the time, acknowledged by
the Institutional Ethical committee and following the national
legislation. Most of the samples come from cases that have been
previously published (see references in the Table 2). The rest of the
myocardial samples were taken as part of the Tampere Coronary
Study, approved by the Ethics Committee of Tampere University
Hospital (DNO 1239/32/200/01) and the Finnish National
Authority for Medico-legal Affairs.
Transgenic animals
Twinkle overexpressor mice were as described in [5] and the
mice expressing Twinkle dup352–364 as in [20].
DNA extraction
Total DNA from frozen autopsy samples was extracted using
proteinase K digestion followed by phenol chloroform extractions
and ethanol precipitation [34].
Enzymatic treatments and agarose gel electrophoresis
1D and 2D-AGE were performed as previously described
[5,17,18]. Restriction digestions and other enzyme treatments
were performed following manufacturers’ recommendations [5].
For a better resolution of dimeric linear molecules on 1D-AGE,
gels presented in figure 5 were 0.5% in contrast to 0.28–0.4% used
in Pohjoisma¨ki et al. [5].
Southern blotting, radiolabelled probes and blot
hybridization
Southern blotting and radioactive detection of DNA was
performed as previously [5,12,34].
Supporting Information
Text S1 Supplementary materials and methods.
Found at: doi:10.1371/journal.pone.0010426.s001 (0.03 MB
DOC)
Figure S1 MtDNA molecules having large scale deletion are
not detected in topology gels in the case of KSS heart sample.
(A) A diagram showing AccI and EcoRI cut sites on human
mtDNA. EcoRI cuts human mtDNA at locations 4121, 5274
and 12640. The 11657:15636 deletion diminishes EcoRI cut
site at nt 12,640, giving rise to a 11.4 kb restriction fragment
instead of a 8 kb one when probed with the OH probe. In
order to estimate mtDNA copy number in the KSS case, the
signal from the full length and deleted OH fragment was
quantified against 18S nDNA signal using phophoimager. The
result was matched against two age-matched controls whose
mtDNA copy number was also measured by qPCR for absolute
values (mtDNA copies per single-copy nuclear gene, APP). (B)
The uncut 12 kb deletion cannot be detected with the same
probe, even after disassembling the high-molecular weight
mtDNA structures using topoisomerase IV (TIV) and T7
endonuclease I (T7). However, large amounts of heterogeneous
molecules are released (seen as smear), suggesting that the
deleted molecules are possibly associated with larger rear-
rangements. (C) 2D-AGE of the 4.8 kb AccI fragment outside
of the KSS deletion shows no difference to the age-matched
control sample.
Found at: doi:10.1371/journal.pone.0010426.s002 (0.26 MB
PDF)
Figure 6. Increase in human heart mtDNA copy number during
childhood correlates with the changes in molecular organiza-
tion. (A) Five-fold increase in mtDNA copy number from newborns to
teen-age. As with the mtDNA organization, individual variation can be
seen in adults. Standard deviation represents three independent
measurements of the same samples. (B) No significant difference in
mtDNA copy number of PolG compound mutant patient heart,
indicating that existence of dimeric mtDNA molecules is independent
of copy number and quantity of branched mtDNA structures. With the
exception of KSS, the mtDNA copy numbers were determined by qPCR
against a single copy nuclear gene (APP). Because of the location of the
cytb amplicon in the deleted region, copy number of the KSS was
determined by Southern hybridization and absolute numbers were
estimated by comparison with two control samples that were
quantified also by qPCR (Figure S1, Text S1).
doi:10.1371/journal.pone.0010426.g006
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